Recombinant Human CXCL5 Protein，His

CXCL5, also known as chemokine (C-X-C motif) ligand 5 or ENA-78, is a member of the CXC chemokine family that plays a critical role in immune response and inflammation. It primarily functions as a chemotactic factor for neutrophils and other immune cells, influencing their migration to sites of inflammation and injury. Elevated levels of CXCL5 have been associated with various pathological conditions, including autoimmune diseases, cancer, and chronic inflammatory disorders. Recent studies have highlighted its potential role in tumor progression and metastasis, as it can modulate the tumor microenvironment and promote angiogenesis. Given these significant implications, recombinant CXCL5 proteins have become a focus of research for therapeutic applications and biomarker development. By producing CXCL5 in a recombinant form, researchers aim to investigate its biological activities, interactions with other cytokines, and signaling pathways involved in immune regulation. Understanding the function of CXCL5 at a molecular level could provide insights into its role in disease processes and unveil novel therapeutic strategies aimed at targeting this chemokine for improved clinical outcomes. Consequently, the characterization and functional analysis of CXCL5-recombinant proteins are essential for progressing our knowledge of immune mechanisms and developing targeted treatments for inflammatory and oncological diseases.